Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Gagnier, J. J.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ACADEMIA AND CLINIC

Reporting Randomized, Controlled Trials of Herbal Interventions: An Elaborated CONSORT Statement

right arrow Joel J. Gagnier, ND, MSc; Heather Boon, PhD; Paula Rochon, MD, MPH; David Moher, PhD; Joanne Barnes, PhD, MRPharmS FLS; Claire Bombardier, MD, for the CONSORT Group*

7 March 2006 | Volume 144 Issue 5 | Pages 364-367

Herbal medicinal products are widely used, vary greatly in content and quality, and are actively tested in randomized, controlled trials (RCTs). The authors' objective was to develop recommendations for reporting RCTs of herbal medicine interventions, based on the need to elaborate on the 22-item CONSORT (Consolidated Standards of Reporting Trials) checklist. Telephone calls were made and a consensus meeting was held with 16 participants in Toronto, Canada, to develop these recommendations. The group agreed on context-specific elaborations of 9 CONSORT checklist items for RCTs of herbal medicines. Item 4, concerning the herbal medicine intervention, required the most extensive elaboration. These recommendations have been developed to improve the reporting of RCTs using herbal medicine interventions.

Author and Article Information
space

From University of Toronto, Institute for Evaluative Sciences, Institute for Work and Health, and Toronto General Research Institute, Toronto, Canada; Children's Hospital of Eastern Ontario, Ottawa, Canada; and University of London, London, United Kingdom.

*The members of the CONSORT Group are listed on the following Web site: http://www.consort-statement.org/Profiles/profiles.html.

Acknowledgments: The authors thank Greer Palloo for aiding in the preparation for the June meeting, and Jaime DeMelo, ND, and Cyndi Gilbert for assisting Joel Gagnier, ND, MSc, and Claire Bombardier, MD, during the actual meeting procedures.

Grant Support: This study was funded in part by an operating grant from the Canadian Institutes of Health Research, Clinical Trials Divisions (ATF-66679). Dr. Gagnier is supported by a postgraduate fellowship from the Canadian Institutes of Health Research and the Natural Health Products Directorate.

Potential Financial Conflicts of Interest: Grants received: J. Barnes (Lichtwer Pharma); Grants pending: J. Barnes (Lichtwer Pharma); Royalties: J. Barnes (Pharmaceutical Press, Churchill Livingstone).

Requests for Single Reprints: Joel J. Gagnier, ND, MSc, 5955 Ontario Street, Unit 307, Windsor, Ontario N81S W6, Canada; e-mail, j.gagnier{at}utoronto.ca.

Current Author Addresses: Dr. Gagnier: 5955 Ontario Street, Unit 307, Windsor, Ontario N81S W6, Canada.

Dr. Boon: University of Toronto, Faculty of Pharmacy, 19 Russell Street, Toronto, Ontario M5S 2S2, Canada.

Dr. Rochon: Baycrest Centre, 3560 Bathurst Street, Toronto, Ontario M6A 2E1, Canada.

Dr. Moher: Children's Hospital of Eastern Ontario Research Institute, 401 Smyth Road, Room 210, Ottawa, Ontario K1H 8L1, Canada.

Dr. Barnes: Centre for Pharmacognosy and Phytotherapy, University of London School of Pharmacy, 29/39 Brunswick Square, London WC1N 1AX, United Kingdom.

Dr. Bombardier: Institute for Work and Health, 481 University Avenue, Suite 800, Toronto, Ontario M5G 2E9, Canada.




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
I. Boutron, D. Moher, D. G. Altman, K. F. Schulz, P. Ravaud, and for the CONSORT Group
Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration
Ann Intern Med, February 19, 2008; 148(4): 295 - 309.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
I. Boutron, D. Moher, D. G. Altman, K. F. Schulz, P. Ravaud, and for the CONSORT Group
Methods and Processes of the CONSORT Group: Example of an Extension for Trials Assessing Nonpharmacologic Treatments
Ann Intern Med, February 19, 2008; 148(4): W-60 - W-66.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
A. M. Whelan, T. M. Jurgens, and L. Lord
Evaluating the Quality of Randomized Controlled Trials that Examine the Efficacy of Natural Health Products: A Systematic Review of Critical Appraisal Instruments
Evid. Based Complement. Altern. Med., January 18, 2008; (2008) nem186v1.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Wu, M. Liu, and Y. Fang
Response to Letter by Bereczki
Stroke, November 1, 2007; 38(11): e143 - e143.
[Full Text] [PDF]


Home page
BMJHome page
E. v. Elm, D. G Altman, M. Egger, S. J Pocock, P. C Gotzsche, J. P Vandenbroucke, and STROBE Initiative
Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies
BMJ, October 20, 2007; 335(7624): 806 - 808.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
E. von Elm, D. G. Altman, M. Egger, S. J. Pocock, P. C. Gotzsche, J. P. Vandenbroucke, and for the STROBE Initiative
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies
Ann Intern Med, October 16, 2007; 147(8): 573 - 577.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
F. Firenzuoli and L. Gori
Herbal Medicine Today: Clinical and Research Issues
Evid. Based Complement. Altern. Med., September 1, 2007; 4(suppl_1): 37 - 40.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
G. Calapai and A. P. Caputi
Herbal Medicines: Can We Do Without Pharmacologist?
Evid. Based Complement. Altern. Med., September 1, 2007; 4(suppl_1): 41 - 43.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
C. Tamayo and S. Diamond
Review of Clinical Trials Evaluating Safety and Efficacy of Milk Thistle (Silybum marianum [L.] Gaertn.)
Integr Cancer Ther, June 1, 2007; 6(2): 146 - 157.
[Abstract] [PDF]


Home page
Integr Cancer TherHome page
S. M. Sagar
Future Directions for Research on Silybum marianum for Cancer Patients
Integr Cancer Ther, June 1, 2007; 6(2): 166 - 173.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
E. M Balk, T. A Horsley, S. J Newberry, A. H Lichtenstein, E. A Yetley, H. M Schachter, D. Moher, C. H MacLean, and J. Lau
A collaborative effort to apply the evidence-based review process to the field of nutrition: challenges, benefits, and lessons learned
Am. J. Clinical Nutrition, June 1, 2007; 85(6): 1448 - 1456.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
V. L. Feigin
Herbal Medicine in Stroke: Does It Have a Future?
Stroke, June 1, 2007; 38(6): 1734 - 1736.
[Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
L. L. d. Santos-Neto, M. A. de Vilhena Toledo, P. Medeiros-Souza, and G. A. de Souza
The Use of Herbal Medicine in Alzheimer's Disease--A Systematic Review
Evid. Based Complement. Altern. Med., December 1, 2006; 3(4): 441 - 445.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2006 by the American College of Physicians.